Browsing Tag
NASDAQ
581 posts
Columbus McKinnon doubles down on $70m synergy target and US demand resilience as post-Kito Crosby execution becomes the entire investment case
Columbus McKinnon ($CMCO) details $70M synergy target, $2.09B FY27 sales guidance, and 5.1x leverage path post-Kito Crosby deal. Full executive analysis here.
Meta slides as an AI executive exit and a hawkish Fed renew scrutiny of its AI strategy
Meta Platforms (META) slides as an AI executive exit and a hawkish Fed renew scrutiny of its AI strategy, even as its ad business stays strong. Full analysis.
Electronic Arts’ $55bn sale looks close, but Europe has added a second regulatory test
Electronic Arts’ $55 billion sale enters EU review as PIF, Silver Lake and Affinity face the July 22 test. Read what its deal spread signals for investors.
Could OpenAI and Anthropic push the next generation of smaller IPOs into SPAC mergers?
SPAC IPOs surge as SpaceX, OpenAI and Anthropic crowd Wall Street’s pipeline. Find out what the revival means for investors and private companies.
Biogen is paying up to $1bn for preclinical optionality. What does RayThera really add?
Biogen's $1 billion RayThera deal expands its immunology pipeline and raises fresh capital allocation questions. Read what BIIB investors should watch next.
Kardigan’s IPO demand looks strong, but the real test for KARD arrives in 2027
Kardigan raises $400 million in an upsized Nasdaq IPO to fund three cardiovascular trials. Discover the catalysts, cash runway and risks for KARD investors.
Innodata’s new CFO inherits a booming AI business and a valuation with little room for error
Innodata names Jayant Chauhan CFO as AI growth accelerates. See how finance discipline, M&A expertise and valuation pressure could shape its next phase now.
WLCOU starts with $200m in cash, but Wilco 63’s biggest test begins after the IPO
Wilco 63 prices a $200 million AI and robotics SPAC IPO. Explore WLCOU terms, sponsor incentives, dilution risks and the acquisition outlook. Read more now.
Smartbird replaces Allbirds as $100m AI infrastructure bet puts BIRD under scrutiny
Find out whether Smartbird’s dramatic AI infrastructure pivot can revive BIRD stock or expose investors to serious execution, funding and dilution risks.
AST SpaceMobile just launched three BlueBirds, but can ASTS still hit its 2026 target?
AST SpaceMobile launches BlueBirds 8, 9 and 10 as ASTS faces a crucial deployment test. Discover what the mission means for satellite broadband growth now.